A common probiotic, Enterococcus faecalis (E. faecalis), was tested to see whether it may inhibit the NLRP3 inflammasome and so prevent colitis and colitis-associated colorectal cancer (CRC) in research by Chung et al. (194). The gene discussed is NLRP3; the disease is colitis.